V. Vijayaprasad*2, B. Nagendra*2, S. Kusumakumari*2, K. Aishwarya1
1Assistant professor, Department of pharmacy practice, CES College of Pharmacy, N.H-7, Chinnatekur, Kurnool, Andhra Pradesh, India.
2Pharm-D student Department of pharmacy practice, CES College of Pharmacy, N.H-7, Chinnatekur, Kurnool, Andhra Pradesh, India.
A B S T R A C T
Guillain-Barre syndrome (GBS) is a rare, complicated neurological rapidly progressive disorder that consists of inflammation of nerves (polyneuritis) causing muscle weakness, sometimes progressing to complete paralysis. Although the precise cause of GBS is unknown, a GI or respiratory infection precedes the onset of the syndrome in about half of the cases. Damage to the covering (myelin) of nerve axons results in delayed nerve signal transmission. It causes weakness of the muscles that are supplied by the damaged nerves. Bell’s palsy is a paralysis or weakness of the muscles on one side of the face. Damage to the facial nerve that controls muscles on one side of the face causes that side of the face to droop.
Keywords: Guillain-Barre syndrome, neurological disorder, muscle weakness, paralysis, bell’s palsy, facial nerve damage